1
|
Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
|
Ophthalmology
|
2006
|
2.72
|
2
|
Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.
|
Arch Ophthalmol
|
2004
|
1.86
|
3
|
Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone.
|
Am J Ophthalmol
|
2005
|
1.30
|
4
|
Familial asymptomatic macular telangiectasia type 2.
|
Ophthalmology
|
2009
|
1.12
|
5
|
Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
|
Ophthalmology
|
2009
|
1.11
|
6
|
Metamorphopsia after successful retinal detachment surgery: an optical coherence tomography study.
|
Acta Ophthalmol Scand
|
2005
|
1.03
|
7
|
Loss of Müller's cells and photoreceptors in macular telangiectasia type 2.
|
Ophthalmology
|
2013
|
1.01
|
8
|
Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial.
|
Ophthalmology
|
2011
|
0.97
|
9
|
Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration.
|
Retina
|
2015
|
0.87
|
10
|
Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial.
|
Clin Experiment Ophthalmol
|
2010
|
0.86
|
11
|
The interaction of indocyanine green with human retinal pigment epithelium.
|
Invest Ophthalmol Vis Sci
|
2005
|
0.86
|
12
|
Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial.
|
Acta Ophthalmol
|
2008
|
0.86
|
13
|
Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia.
|
Br J Ophthalmol
|
2012
|
0.85
|
14
|
Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.85
|
15
|
Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema.
|
Br J Ophthalmol
|
2007
|
0.83
|
16
|
In vitro study of the effects of lens extract on rat retinal neuron survival and neurite outgrowth.
|
Ophthalmic Res
|
2009
|
0.81
|
17
|
Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial.
|
Invest Ophthalmol Vis Sci
|
2009
|
0.81
|
18
|
Anti-retinal antibodies in patients with macular telangiectasia type 2.
|
Invest Ophthalmol Vis Sci
|
2013
|
0.81
|
19
|
Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes.
|
Ophthalmic Res
|
2015
|
0.80
|
20
|
Basement membrane changes in capillaries of the ageing human retina.
|
Br J Ophthalmol
|
2011
|
0.79
|
21
|
Intravitreal injection of triamcinolone acetonide for immune recovery uveitis.
|
Retina
|
2006
|
0.76
|
22
|
Triamcinolone for occult exudative age-related macular degeneration.
|
Am J Ophthalmol
|
2006
|
0.75
|
23
|
Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial.
|
BMC Ophthalmol
|
2014
|
0.75
|
24
|
Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema.
|
Clin Ophthalmol
|
2013
|
0.75
|
25
|
Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes.
|
Ophthalmologica
|
2017
|
0.75
|
26
|
Reply.
|
Cornea
|
2017
|
0.75
|
27
|
Influence of Retinal Pathology on the Reliability of Macular Thickness Measurement: A Comparison Between Optical Coherence Tomography Devices.
|
Ophthalmic Surg Lasers Imaging Retina
|
2017
|
0.75
|
28
|
Measurement of retinal arteriolar diameters from auto scale phase congruency with fuzzy weighting and L1 regularization.
|
Conf Proc IEEE Eng Med Biol Soc
|
2012
|
0.75
|
29
|
Intravitreal triamcinolone.
|
Ophthalmology
|
2009
|
0.75
|